TECHWIRE 30
(CIX: WRAL30)  1,136.25  up arrow+9.65  (0.86 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: Apple)  112.94  up arrow+1.16  (1.04 %)  Updated: 08:10 PM EST, Dec 22 2014
(NY: QUINTILES)  60.09  down arrow-0.3  (-0.5 %)  Updated: 06:40 PM EST, Dec 22 2014
(OP: BASF SE)  86.23  up arrow+1.08  (1.27 %)  Updated: 05:20 PM EST, Dec 22 2014
(NQ: BioCryst)  11.13  down arrow-0.03  (-0.27 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: BioDelivery)  13.43  down arrow-0.39  (-2.82 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: CEMP)  21.40  up arrow+0.09  (0.42 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: Cisco Systems)  28.22  up arrow+0.45  (1.62 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: Cree)  32.13  up arrow+0.92  (2.95 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: DARA)  0.85  down arrow-0.03  (-2.86 %)  Updated: 08:10 PM EST, Dec 22 2014
(NY: EMC CORPORATION)  30.44  up arrow+0.3  (1 %)  Updated: 06:40 PM EST, Dec 22 2014
(NQ: Extreme Networks)  3.45  up arrow+0.01  (0.15 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: FB)  81.45  up arrow+1.57  (1.97 %)  Updated: 08:10 PM EST, Dec 22 2014
(NY: GLAXOSMITHKLINE)  43.44  up arrow+0.09  (0.21 %)  Updated: 06:40 PM EST, Dec 22 2014
(NQ: GOOG)  524.87  up arrow+8.52  (1.65 %)  Updated: 08:10 PM EST, Dec 22 2014
(NY: IBM)  161.44  up arrow+2.93  (1.85 %)  Updated: 06:40 PM EST, Dec 22 2014
(NY: LH)  107.14  up arrow+1.34  (1.27 %)  Updated: 06:40 PM EST, Dec 22 2014
(OP: Lenovo Group)  26.16  down arrow-0.22  (-0.83 %)  Updated: 05:20 PM EST, Dec 22 2014
(NY: MRK)  58.96  down arrow-0.62  (-1.04 %)  Updated: 06:40 PM EST, Dec 22 2014
(NQ: Microsoft Corp)  47.98  up arrow+0.32  (0.67 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: NTAP)  42.94    (0 %)  Updated: 08:10 PM EST, Dec 22 2014
(NY: NOVARTIS AG)  95.30  up arrow+0.69  (0.73 %)  Updated: 06:40 PM EST, Dec 22 2014
(OP: Novozymes A/S)  43.75  up arrow+0.64  (1.48 %)  Updated: 05:20 PM EST, Dec 22 2014
(NY: PFIZER)  32.09  up arrow+0.15  (0.47 %)  Updated: 06:40 PM EST, Dec 22 2014
(NQ: Pozen)  7.92  down arrow-0.25  (-3.06 %)  Updated: 08:10 PM EST, Dec 22 2014
(NY: RED HAT)  68.89  up arrow+0.85  (1.25 %)  Updated: 06:40 PM EST, Dec 22 2014
(NQ: BBRY)  10.68  up arrow+0.69  (6.86 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: Salix)  117.46  up arrow+0.26  (0.22 %)  Updated: 08:10 PM EST, Dec 22 2014
(NQ: SQI)  14.60  down arrow-0.37  (-2.47 %)  Updated: 08:10 PM EST, Dec 22 2014

Posts tagged “Biotech & Life Science”

6:20 a.m. yesterday

News in review: WTW's 50 headlines from last week

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

6:00 a.m. yesterday

Are you, your company making news? Have an opinion? Share it with WTW

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

December 18

Premium Lock Pozen's latest headache: Another FDA delay in drug approval

2014 is coming to a miserable close for Chapel Hill-based Pozen. After its stock was pummeled 30 percent when Pozen and drug giant Sanofi mutually terminated a $35 million drug deal earlier this month, on Wednesday Pozen disclosed another FDA delay in approval of a new pain killer.

Pozen's headaches Pozen's headaches

December 18

Durham life science firm Health Decisions names interim CEO

Dr. Stephen DeCherney is the newly named interim chief executive officer at life science services firm Health Decisions. Dr. Michael Rosenberg, the firm's founder and CEO, was killed in a plane crash in Maryland last week.

Dr. Stehpen DeCherney Dr. Stehpen DeCherney

Updated December 17

Premium Lock Will Red Hat deliver earnings surprise? New IBM deal may be boost

Red Hat     Red Hat is set to announce its latest quarterly financials on Thursday, and Wall Street won't be surprised if the Hatters deliver better-than-expected results. Or will the Hatters disappoint? A new IBM deal may give Red Hat a boost going forward.

December 17

Salix stock rebounds on news of inventory reduction plan

A slide from a Salix presentation Salix Pharmaceuticals shares rebounded 7 percent Tuesday on news that the Raleigh-based company will launch a plan to reduce drug inventory by the end of 2015. Salix was rocked in November when it acknowledged big inventory problems.

Updated December 16

Despite layoffs at GSK, raise a glass (at least) half full

Veteran journalist Jim Shamp sees upside and downside in the recently announced job cuts at GlaxoSmithKline. After all, he notes, cuts in the past as GSK evolved locally from Burrough Wellcome to Glaxo to Glaxo Wellcome and today have produced a harvest of new companies, new ideas, and products. "Yes, a shakeup like GSK's cutback announcement is shattering," he writes. "But these are smart, talented people who will get back on their feet and contribute greatly to North Carolina's life science future."

GSK Headquarters      GSK Headquarters

December 15

RTP drug firm launching clinical trial of possible Ebola treatment

Ebola RTP-based BioCryst Pharmaceuticals is launching a clinical trial of a potential treatment for Ebola with funding support from the U.S. government. Durham-based Chimerix and GSK also are involved in the Ebola battle.

December 15

Week in review: WRAL TechWire's 61 headlines

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

December 15

Is your company making news? Have an opinion? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

December 12

#WTWTrends: Follow Friday, Ebolo, WCPSS and Hour of Code, IoT, Wake Army Trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Friday, Dec. 12, 2014 as curated by @WRALTechWire.

Updated December 12

Premium Lock Winston-Salem startup joins fight against Ebola with eData

Another North Carolina company is joining the fight in the field against Ebola, but this time not as a provider of a possible vaccine. Winston-Salem based Clinical Ink is being used by a number of firms in the Ebola battle to provide clinical trial data safely through its eData platform.

Clinical Ink joins Ebola fight Clinical Ink joins Ebola fight

December 12

'Make an offer' at Amazon; more NC solar; US lags in drones; Merck breast cancer drug advances

Bulldog In today's Bulldog wrapup of technology and life science news: Amazon unveils a "make an offer" service; more new solar sites in North Carolina; Congress told U.S. trails in drones for commercial use; and a Merck breast cancer drug advances.

Updated December 11

Backers pledge $390M for Ebola; side effects delay one trial

Ebola Even as backers pledged $390 million for Ebola vaccines, Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects. It's not the vaccine being tested by GlaxoSmithKline.

Updated December 10

#WTWTrends for Wednesday: Lenovo recall, Ebola, Uber, texting and driving Trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Wednesday, Dec. 10, 2014 as curated by @WRALTechWire.

Updated December 10

A second Durham exec, another Health Decisions employee died in plane crash

Chiji Ogbuka Three employees of the Triangle pharmaceutical sciences community were killed in a Monday plane crash in suburban Washington, D.C. Health Decisions CEO Dr. Michael Rosenberg was killed along with David Hartman, a vice president at Nuventra and Chiji Ogbuka, who worked for Health Decisions.

Updated December 10

Premium Lock Blue Cross Blue Shield subsidiary invests $4M in Durham health startup

Mosaic Health Solutions TouchCare, a startup that has developed a mobile app to remotely connect patients and healthcare providers, has landed an equity investment from Mosaic Health Solutions, a subsidiary of Blue Cross and Blue Shield of North Carolina.

Updated December 9

NC firms help lead Ebola fight but face multiple battles

Several North Carolina firms are at the forefront of developing new treatments for the Ebola virus, but they face challenges in testing and delivering them, executives from Chimerix, Quintiles and GlaxoSmithKline say at a conference in RTP.

GSK's Donna Altenpohl GSK's Donna Altenpohl

December 9

#WTWTrends for Tuesday: Google Fiber, Ebola, RTP Startups and Cam Newton Trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Tuesday, Dec. 9, 2014 as curated by @WRALTechWire.

Updated December 9

North Carolina is at forefront of fighting Ebola threat

Ebola North Carolina is on the forefront of preparation for a potential Ebola crisis as well as helping fight global outbreaks of the dreaded disease, said representatives from the state and national government, the Triangle health care profession, and Triangle private industry at Monday's Ebola Conference at the North Carolina Biotechnology Center.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll